Letters to the Editor
Pesticide residues in food From Dr D G Mayne Area Hospital, Craigavon Dear Sir, The paper by Dr G J Turnbull (November 1984 Journal, p 932) seems to support a different outcome to that of Dr Jean Munro (1984) who helps patients with environmental illness recover from excess 'chemical loads' (Rea et al. 1978) . In the USA the problem of sprays is much more carefully controlled. The extent of the exposure is only just becoming appreciated (Steering Committee 1984) but the vast number of chemicals is increasing like a flood each year. In Germany the chemical industry is spending heavily to counter this danger, but this is not happening here (Lampkin 1974 (1984) Toxicity Testing. National Academy Press, Washington DC From Dr David Ratner Director ofEmergency Services Central Emek Hospital, Afula, Israel Sir, I read with great interest the paper by Dr G J Turnbull (November 1984 Journal, p 932) . Unfortunately, the situation in our area-and, I suspect, in many other countries-is not quite as benign as the author would have us think. Since our paper reporting 5 patients with chronic dietary anticholinesterase poisoning secondary to ingested pesticide residues in fresh fruits and vegetables (Ratner et al. 1983) , we have documented another 20 cases.
In countries where the supervision, control and monitoring of pesticide usage are inadequate, excessive residues are likely to appear in food. This is particularly true when the pesticides are used systemically: the pesticide enters the plant via the root system and is found in the edible portion of the fruit; of course, the usual washing and peeling are to no avail. In our experience many agricultural workers do not fully understand the complications and instructions concerning the use of pesticides. It is not amusing to watch a semiliterate field hand holding a container of Timek (aldicarb) and trying to comprehend the written instructions concerning dilution, method and frequency of use, and time interval between use and harvesting. Our main problem concerns anticholinesterase agents of both the organophosphorus and carbamate groups.
When 'sloppy' use is combined with excessive dietary intake, the results can be quite devastating. Particularly at risk are vegetarians, food faddists and so-called 'weight-watchers', whose daily consumption of fresh fruits and vegetables is usually above average. We agree with Dr Turnbull that the dose determines the danger. Consequently the practising physician should be aware of the fact that occasionally dietary pesticide intake can be a clinical problem. Copies of these letters were sent to Dr Turnbull, who replies as follows:
Sir, Contrary to Dr Mayne's belief, the USA does not control pesticide spraying any more carefully than has for a long time been the case in Western Europe. Neither has the extent of exposure only just become appreciated, nor is it true that 'the vast number of chemicals is increasing like a flood each year'. The German chemical industry is spending no more heavily on safety studies than is happening in Great Britain or the USA for the simple reason that the commercial viability of a pesticide depends upon international use on major crops.
As a toxicologist I question the existence of an environmental illness involving a response to an undefined 'chemical load' which fails to manifest any semblance of a dose-response relationship. Subtle effects at extremely low dosages presage unmistakable effects at higher dosages for both manmade and natural chemicals. Where is the evidence of a gradation in measurable 'chemical load' correlated with so-called environmental illness of increasing severity?
With regard to the letter from Dr Ratner, pesticides are restricted nationally and internationally to uses which result in residues in food which are acceptably low, i.e. present no risk to health. The regulations ensure that only by flagrant abuse of good agricultural practice and failure to adhere to any specified pre-harvest interval is there a possibility of potentially harmful intake of residues. That applies even when the crop is a major portion of the diet and the pesticide is used at the maximum recommended concentration and frequency.
I suggest that very rarely will there be an illness involving pesticide-induced anticholinesterase effects without there being a history of gross occupational exposure in field work due to neglect of proper precautions. The highest potential intake of residues will be from treating a leafy food crop, like lettuce, too soon before harvest. Systemic transfer of pesticide within a plant to the edible portions will not give rise to harm from residues provided the label instructions are followed. However, outright misuse of, for example, aldicarb which is notably toxic and therefore severely restricted, has resulted in rare non-fatal poisoning by this mechanism (Hayes 1982). Residue levels in crops can readily be determined by analysis and a suspected ingestion confirmed or excluded as the cause of illness.
The problem lies in obtaining accurate information, particularly if the patient has consumed a crop treated with a pesticide in a manner contrary to instructions. The local physician has an important role to play in identifying cases of illness due to 'sloppy' use of pesticides (or any other chemical). The bodies responsible for supervision, control and monitoring of pesticide usage can only respond if they are alerted to the problem. The remedy then lies in education, field training and sometimes licensing of agricultural pesticide users, communication of hazard information and the re-evaluation of warning labels on products and of the list of permitted uses.
A series of cases, such as that mentioned by Dr Ratner, is cause for concern, and yet a sense of proportion must prevail. In those countries where reliable monitoring and statistics are available, there are no recorded instances of ill effects in persons consuming agricultural commodities which have been treated with pesticides in accordance with recommended practice. In countries which lack reliable systems for national reporting of occupational illness and accidental poisoning, published reports of poisoning cases are an important record provided that factors contributing to the over-exposure are all identified. Speech production after laryngectomy From Ms Alison Perry ChiefSpeech Therapist Charing Cross Hospital, London Dear Sir, I am writing to express my deep concern about the paper by Mr Anthony Priest, a laryngectomee, which is highly critical of the speech therapy profession (December 1984 Journal, p 1020).
The paper is, naturally, highly biased. Sadly, Mr Priest assumes that his own experience of ineffectual speech therapy is 'typical'. He makes many highly personal, contentious points, none of which is borne out in his paper by references to established work currently being undertaken. An example of this is the erroneous statement that 'there is no reason why a patient should not be able to talk'. In fact, a recent paper by Cheesman et al. (1985) , in looking at a series of over 50 'failed' oesophageal speakers after laryngectomy, cites very clear and unequivocal physical reasons why approximately 40% of laryngectomees overall fail to develop voice. Many of these problems, which are directly related to the surgical closure of the pharynx at the time of laryngectomy, are not amenable to therapy (even by a fellow patient!) and require further surgical correction.
Mr Priest's view that 'normal therapists cannot teach by example' is like suggesting that a surgeon needs to have a broken leg to operate successfully on a fractured femur! In fact, of course, many speech therapists can, and do, produce good oesophageal voicedespite having a larynx.
The essence of Mr Priest's cri de coeur would seem to be that speech therapists are not trained to deal with laryngectomy. This has to be seen in the context of the number (about 500) of new laryngectomees a year. These patients are spread through all the district general hospitals in Britain, so most speech therapists are unlikely to see more than one new laryngectomee per year. In an attempt to rectify this lack of experience with laryngectomees, 8 speech therapists currently working in the UK have, over the years, raised their own funding to attend the Mayo Clinic Laryngectomee Rehabilitation Seminar in Rochester, USA, in order to gain the wider, deeper level of expertise that was recogized to be so needed. These same therapists, now with a specific expertise in this field, have gradually built up a network of courses, training sessions, lectures, etc., for newly qualified speech therapists to call upon in this country.
In my own unit at Charing Cross Hospital, 6-8 'new' laryngectomees are seen per month for surgical voice restoration. The majority of these are 'failed' oesophageal speakers. Sadly, without the diagnostic skills of the radiology, ENT and speech therapy team, many of these patients have been labelled as 'lazy' or lacking in motivation. In fact, all have been shown to have very marked anatomical/physiological barriers to acquiring oesophageal speech. The danger with laryngectomees like Mr Priest treating 'their' patients is that they do not have as full and comprehensive an understanding of the mechanism of oesophageal voice production or have access to full case history and diagnostic information on patients, and are therefore likely to make erroneous assumptions.
Speech therapy is a complex interaction of psychological support, family counselling and advising on the full range of communication possibilities, as well as teaching oesophageal voicewhich is only one of a variety of methods of communication available. The existence of oesophageal speech teachers has been long established in the USA, where laryngectomees who use oesophageal voice assume they can provide voice therapysometimes with long-term effects of bad habits acquired by new patients, which therapists then have to rectify. Mr Priest makes the comment that 'although they [speech therapists] understand the theory, the practice is so different'. I would suggest that the reverse is true of Mr Priest: although he understands the practice, the theory is very different. A good therapist, however, has a complete understanding of both. One needs to know a variety of means of producing oesophageal voicenot just by pumping air (or injection) which he cites as his therapy programme. Whilst welcoming Mr Priest's obvious concern and commitment to helping his fellow patients, I would be very concerned at the ethics of referring any patient to either a therapist or a laryngectomee who did not have a complete understanding of the mechanics of oesophageal voice production. From Mrs Jane Baker Scarborough Dear Sir, As a speech therapist with some experience of treating laryngectomy patients, I was concerned to read Mr Anthony Priest's do-ityourself speech therapy guide (December 1984 Journal, p 1020).
I am sure that Mr Priest has every reason to be proud of his voice. However, many patients are not as intelligent as Mr Priest and do require the help and reassurance of professionals.
Our treatment aims not just to help the patient achieve as good a voice as possible, but to help him with the enormous problems of readjustment.
Our training equips us to diagnose and treat many disorders of communication. As in any profession, experience teaches one a great deal and there is no doubt that some speech therapists have more experience in this field than others.
JANE BAKER
Copies of these letters were sent to Mr Priest, whose reply follows: Sir, Ms Perry quotes me out of context. I did, in fact, say that 'unless there is a deep-seated psychological reason, or extensive surgery has made it impossible, there is no reason why a patient should not be able to talk'. Thus we do appear to be largely in agreement on this point.
Ms Perry is indeed fortunate to have more experience in this field than many of her colleaguesbut she is not a laryngectomee. When we are told that the good speech therapist can produce an oesophageal voice, are we talking about ventriloquism? To understand fully the 'know how' of the oesophageal or pharyngeal voice, one must serve a practical apprenticeshipboth psychological and physical. Any rehabilitated laryngectomee will confirm this.
That laryngectomees have a place as teachers of other laryngectomees has long been recognized in the USA. All the patients that I see are monitored by the consultant surgeon concerned at his regular clinics, and instruction taken from him as to the readiness and physical ability of those patients to start or discontinue instruction.
In reply to Mrs Jane Baker, I can only say that the patient must do it himselfwith all the encouragement and expertise at his disposal. Warneford Hospital, Leamington Spa Sir, As the laryngologist who supported and advised Mr Priest on his paper, I would like to make the following points in response to Ms Perry's letter. Ms Perry also gave an excellent paper at the same meeting as Mr Priest, and I was struck by the similarity of their papers despite their different viewpoints.
Mr Priest did mention that extensive surgery might make speech impossible. His criticism of speech therapists is based on his experience and papers written by speech therapists: for example, Miss Gaye Murrils, one-time Chief Speech Therapist at Charing Cross Hospital, from whose paper to the Laryngectomy Rehabilitation Seminar in 1978 he quoted verbatim. I feel that selected laryngectomee volunteers should work under the guidance of a professional speech therapist. In South Warwickshire guidelines have been established for the use of such volunteers, so that practice and theory can combine to the advantage of patients. Any disagreement that there may be is referred to the laryngologist who is responsible for the patient's care.
Mr Priest's paper has produced a great deal of reaction both from speech therapists and from laryngectomees and will, I think, influence the way voice production after laryngectomy is managed, and lead to a clearer definition of the place of laryngectomee volunteers. [416] [417] .
The major problems in interpreting data on the management of patients with severe Graves' ophthalmopathy are, first, that because the disease is uncommon, the literature is bedevilled by reports of isolated cases, uncontrolled trials or series too small to allow firm conclusions to be drawn; and secondly, that assessment of patients is too often based on soft subjective criteria. Studies using cyclosporin A or plasma exchange in the treatment of Graves' ophthalmopathy still suffer from these shortcomings and before firm conclusions can be reached on the likely value of these modes of therapy, more information is required.
In studying patients with Graves' ophthalmopathy treated with cyclosporin, having initially reported encouraging results in 2 patients treated with the agent (Weetman et al. 1983 ), we have sought to collect a more substantial group of patients in whom objective assessment of their response to cyclosporin A might be examined. Eleven patients have now completed our protocol. The data obtained, currently in preparation for publication, are summarized briefly here.
It was intended that all patients would receive cyclosporin A alone for 3 months at a dose of 10mg/kg body weight. Three patients failed to complete the course of therapy (2 because of disease progression and one because of a lifethreatening episode of Legionnaires' disease, though the latter patient was subsequently restarted on cyclosporin A). In 3 patients (including the one who developed Legionnaires' disease) reducing doses of oral steroids continued to be administered during therapy with cyclosporin A.
Monitoring of renal and liver function during treatment demonstrated alterations in serum creatinine levels in 5 patients; these returned to normal on reducing the dose of cyclosporin A to 5 mg/kg body weight. The only other commonly observed side effect was hypertrichosis, noted in 5 women, which resolved spontaneously when they completed their course of cyclosporin A.
Subjectively there was an impressive response to therapy. Symptoms scored by patients on a score of 0 to 3 (nil to severe), when pooled for the group, totalled 80 prior to cyclosporin A and 29 after! With the exception of one patient who received only one month's treatment because of disease progression, all reported some improvement in their symptoms. When objective criteria (visual fields, visual acuity, colour vision, eye movements, proptosis, periorbital oedema, chemosis, and intraocular pressure on upward gaze), using the same scoring system, were assessed serially prior to and following cyclosporin A, the difference was far less dramatic, being 122 and 87 respectively. Furthermore, assessment of eye muscle size by CT scanning in the group who had pre-and post-cyclosporin A assessment (n=7) showed improvement in eye muscle size in 2, no change in 4 and further enlargement in one. As a further criterion of assessment of success or otherwise of this therapy, it is noteworthy that following their course of cyclosporin A all but 4 patients required the introduction (or continuation) of steroid therapy.
On the basis of our own objective criteria, we feel that only 4 of the 11 patients could be shown to have benefited from cyclosporin A therapy. We still feel that more information is required in order to define more clearly those most likely to benefit from this treatment and, when appropriate patients become available, we will continue to consider the use of cyclosporin A in their management.
Whilst Dr Kelly and his colleagues have alluded to only negative reports relating to the use of cyclosporin A in Graves' ophthalmopathy, we are aware of 2 reports (still in abstract form) which suggest a much more encouraging outcome (Witte et al. 1984 , Utech et al. 1984 . Until more information is available on the use of cyclosporin A in Graves' ophthalmopathy in particular, but also in autoimmune disease in general, it is better not to talk of cyclosporin's 'undeserved reputation for efficacy'. ALAN A copy of this letter was sent to Dr Dijkstra, whose reply follows: Sir, I fear Dr Gibbons has missed my point. My observations showed that depletion of the iron reserves, due either to repeated bleeding or one major, insufficiently restored blood loss, can cause the initial symptoms of the syndrome. Our patients did not show anaemia, atrophic glossitis or angular cheilitis, but only swallowing difficulties and lowered serum iron levelssymptoms which proved to be a true crux medicorum.
As post-cricoid cancer is thought to be related to the full Brown-Kelly-Paterson/Plummer-Vinson syndrome, my observations might have practical consequences: repeated donation of blood might not be as harmless as is usually presumed. In our patients massive doses of iron proved not to replenish iron stores, though low doses over a longer time did. (May Journal, p 418) about the case we reported (December 1984 (December , p 1048 and were as interested as he in the source of the organism. The patient had no active gingivitis or periodontitis and no dental treatment was needed, so we presume dental plaque to have been the likely origin. The aspiration of a traumatic haematoma over his right elbow was the only recent invasive procedure, and we propose this might have been colonized following transient bacteraemia of dental flora. The Centers for Disease Control did not report on the production of any leukotoxin in this strain. It would have been instructive, in retrospect, to investigate the leukotoxic effect of this organism in the presence of normal human serum, as this activity may be neutralized by an infected patient's own serum (Baehni et al. 1981 ).
We did not perform a wide range of neutrophil function tests, and confined our attention to the presence of 'opsonizing' antibody. We appreciate that luminol-dependent chemiluminescence does not necessarily parallel phagocytosis, although it does in most systems of neutrophils and bacteria. However, it is a measure of the binding of organisms to the neutrophil surface, and it is reasonable to assume that this is mediated via specific antibody. It would have been useful to confirm phagocytosis of the organisms with electron microscopy and also to test the bactericidal activity of the neutrophils, but neither of these was done. Despite this, we feel our data strongly suggest the presence of opsonizing antibody in the patient's serum, which can either bind through the neutrophil Fc receptor or can activate complement and enhance opsonization through complement receptors.
We apologise for the misprint in Figure 1 : the chemiluminescence release is indeed measured in mV. 
Department of Psychiatry
Centre Hospitalier de Romans, France Sir, I was very interested to read the case report by James et al. (October 1984 Journal, p 882) . At about the same time we reported a similar case (Luaute et al. 1984) ; however, we preferred to restrict the diagnosis to schizophrenia until the association of an AMN was proven.
The use of the term 'schizophrenia' (instead of 'schizophreniform psychosis', which is ambiguous) raises two matters:
(1) The evidence that schizophrenia may originate from specific (and various) diseases of the CNS must stimulate the search for such causesfor instance, latent AMN. Thus schizophrenia appears to be a syndrome and not a disease.
(2) If one continues to believe in the existence of an idiopathic disease called schizophrenia, the study of the symptomatic forms of this disease may be of great heuristic value. The well-known occurrence of schizophrenic features in metachromatic leukodystrophy (Kothbauer et al. 1977 ) and now in AMN could be linked with abnormalities of the white matter which have been recently discovered by CAT scan in 'genuine' schizophrenias (Largen et al. 1984) , and gives weight to the hypothesis of a disturbance of the neuronal circuitry. For this reason, the use of nuclear magnetic resonance scanning, as described by James et al., is indicated.
